| 000 | 01780 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516151120.0 | ||
| 264 | 0 | _c20140304 | |
| 008 | 201403s 0 0 eng d | ||
| 022 | _a1552-4604 | ||
| 024 | 7 |
_a10.1002/jcph.97 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAnderson, Matt S | |
| 245 | 0 | 0 |
_aEffects of Rifampin, a potent inducer of drug-metabolizing enzymes and an inhibitor of OATP1B1/3 transport, on the single dose pharmacokinetics of anacetrapib. _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacology _cJul 2013 |
||
| 300 |
_a746-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP3A _xmetabolism |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInactivation, Metabolic |
| 650 | 0 | 4 | _aLiver-Specific Organic Anion Transporter 1 |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrganic Anion Transporters _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOrganic Anion Transporters, Sodium-Independent _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOxazolidinones _xadministration & dosage |
| 650 | 0 | 4 |
_aRifampin _xadverse effects |
| 650 | 0 | 4 | _aSolute Carrier Organic Anion Transporter Family Member 1B3 |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aCote, Josee | |
| 700 | 1 | _aLiu, Yang | |
| 700 | 1 | _aStypinski, Daria | |
| 700 | 1 | _aAuger, Patrice | |
| 700 | 1 | _aHohnstein, Anne | |
| 700 | 1 | _aRasmussen, Scott | |
| 700 | 1 | _aJohnson-Levonas, Amy O | |
| 700 | 1 | _aGutstein, David E | |
| 773 | 0 |
_tJournal of clinical pharmacology _gvol. 53 _gno. 7 _gp. 746-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jcph.97 _zAvailable from publisher's website |
| 999 |
_c22748154 _d22748154 |
||